Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Oral Semaglutide in People With Mild Cognitive Impairment or Mild Dementia of the Alzheimer’s Type

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Bulgaria Czechia Denmark Finland +15
  • Study on Thiethylperazine and Florbetaben (18F) for Early Alzheimer’s Disease Patients

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany
  • Study on Donanemab, Florbetapir, and Flortaucipir for Patients with Early Alzheimer’s Disease

    Not recruiting

    2 1
    Investigated Diseases:
    Czechia The Netherlands Poland
  • Study on AVP-786 for Treating Agitation in Alzheimer’s Dementia Patients

    Not recruiting

    3 1
    Investigated Diseases:
    Belgium Croatia Hungary Ireland The Netherlands Slovakia +2
  • Study of Trontinemab Compared to Placebo for Patients with Early Symptomatic Alzheimer’s Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    Denmark France Germany Italy The Netherlands Poland +1
  • A Study to Test the Long-term Safety and Benefits of GSK4527226 in Patients with Early Alzheimer’s Disease

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Finland France Germany Italy The Netherlands Norway +2
  • A study testing MK-1167 added to current treatment in patients with mild to moderate Alzheimer’s disease dementia

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Italy The Netherlands Spain
  • A Study of Donanemab in People With Early Symptomatic Alzheimer’s Disease

    Not recruiting

    3 1 1
    Poland Spain
  • Study of RO7126209 safety and effects given by intravenous infusion in patients with early stage or mild to moderate Alzheimer’s disease

    Not recruiting

    1 1
    Poland Spain
  • Study of microglial activation and synaptic density using [18F]-DPA-714, [18F]-Ro948, [11C]-UCB-J, and [11C]PiB PET imaging in patients with Alzheimer’s disease

    Not recruiting

    2 1 1
    Investigated Diseases:
    France